Literature DB >> 1372532

Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro.

F S Kittrell1, C J Oborn, D Medina.   

Abstract

A series of mouse mammary epithelial cell lines has been established by a protocol that gives highly reproducible results. The mammary epithelial cell lines, designated as FSK lines, were judged to be epithelial based on positive immunostaining for keratin-intermediate filaments, negative immunostaining for vimentin-intermediate filaments, hormonal induction of casein, and the ability to exhibit ductal and alveolar mammary morphogenesis in vivo. The FSK cell lines are dependent on epidermal growth factor and insulin in a low serum (1%) medium. Conditioned medium from spindle cell cultures replaced the requirement for serum and increased the growth of FSK3 and FSK4 4-5 times in collagen gels and 12-14 times in monolayer culture, respectively. Following injection into the mammary fat pad at passages 2-11, the FSK cell lines generated stable transplantable hyperplastic alveolar outgrowth lines. The in vivo outgrowth lines were judged as preneoplastic based on their stable alveolar morphology in vivo and an increased susceptibility for tumorigenesis. The FSK cell lines and their derivative in vivo outgrowth lines provide a new and potentially productive system to examine critical molecular alterations involved in the development of mammary preneoplasias. Furthermore, the reproducibility of the in vitro culture system provides the assurance that stable cell lines of mouse mammary epithelial cells can be generated easily and at will.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372532

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  Transfection of mouse mammary epithelial cells.

Authors:  C A Hollmann; D Medina; J S Butel
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

Review 2.  Three-dimensional mammary primary culture model systems.

Authors:  M M Ip; K M Darcy
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

Review 3.  A free-radical hypothesis for the instability and evolution of genotype and phenotype in vitro.

Authors:  R E Parchment; K Natarajan
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

Review 4.  Cell cycle genes in a mouse mammary hyperplasia model.

Authors:  Thenaa K Said; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

5.  Regulation of breast cancer-induced bone lesions by β-catenin protein signaling.

Authors:  Yan Chen; Heidi Y Shi; Stuart R Stock; Paula H Stern; Ming Zhang
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

6.  Establishment and characterization of a lactating dairy goat mammary gland epithelial cell line.

Authors:  Hui-Li Tong; Qing-Zhang Li; Xue-Jun Gao; De-Yun Yin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-01-20       Impact factor: 2.416

7.  Conjugated linoleic acid induces apoptosis of murine mammary tumor cells via Bcl-2 loss.

Authors:  Lihui Ou; Clement Ip; Barbara Lisafeld; Margot M Ip
Journal:  Biochem Biophys Res Commun       Date:  2007-03-26       Impact factor: 3.575

8.  Growth factor signaling induces metastasis genes in transformed cells: molecular connection between Akt kinase and osteopontin in breast cancer.

Authors:  Guoxin Zhang; Bin He; Georg F Weber
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

9.  Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition.

Authors:  Khatri Latha; Weiguo Zhang; Nathalie Cella; Heidi Y Shi; Ming Zhang
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53.

Authors:  L L Kelley; W F Green; G G Hicks; M C Bondurant; M J Koury; H E Ruley
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.